0001209191-15-018691.txt : 20150225 0001209191-15-018691.hdr.sgml : 20150225 20150225172918 ACCESSION NUMBER: 0001209191-15-018691 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150223 FILED AS OF DATE: 20150225 DATE AS OF CHANGE: 20150225 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daly James M CENTRAL INDEX KEY: 0001560782 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 15649084 MAIL ADDRESS: STREET 1: INCYTE CORPORATION EXPERIMENTAL STATION STREET 2: RTE 141 & HENRY CLAY RD. BLDG E336 CITY: WILMINGTON STATE: DE ZIP: 19880 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-02-23 0 0000879169 INCYTE CORP INCY 0001560782 Daly James M 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 0 1 0 0 EVP, Chief Commercial Officer Common Stock 2015-02-23 4 M 0 2778 18.32 A 6299 D Common Stock 2015-02-23 4 S 0 2778 83.44 D 3521 D Common Stock 2015-02-24 4 M 0 7732 16.62 A 11253 D Common Stock 2015-02-24 4 M 0 602 16.62 A 11855 D Common Stock 2015-02-24 4 S 0 8334 81.77 D 3521 D Non-Qualified Stock Option (right to buy) 18.32 2015-02-23 4 M 0 2778 0.00 D 2020-02-08 Common Stock 2778 27877 D Non-Qualified Stock Option (right to buy) 16.62 2015-02-24 4 M 0 7732 0.00 D 2019-10-21 Common Stock 7732 61855 D Non-Qualified Stock Option (right to buy) 16.62 2015-02-24 4 M 0 602 0.00 D 2019-10-21 Common Stock 602 4813 D Represents weighted average sale price. Actual sale prices ranged from $82.79 - $83.58. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. Represents weighted average sale price. Actual sale prices ranged from $80.73 - $83.39. Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Beginning October 22, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. /s/ James M. Daly 2015-02-25